INTERPARFUMS, INC.: 10-Q filed 2025-11-05
What INTERPARFUMS, INC. reported in its quarterly report filed 2025-11-05 (fiscal Q3 2025): 43 published measures, 117 facts as tagged in accession 0001753926-25-001703.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2025-11-05
- Fiscal period
- fiscal Q3 2025
- Accession
- 0001753926-25-001703 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INTERPARFUMS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 1,564,650,000 | USD | |
| At 2024-12-31 | 1,411,261,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 870,887,000 | USD | |
| At 2024-12-31 | 744,871,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 65,809,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 140,289,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 62,259,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 140,130,000 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 68,373,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 49,681,000 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 22,866,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 2,889,000 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | -90,852,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | -71,934,000 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | -1,842,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 11,569,000 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 826,964,000 | USD | |
| At 2024-12-31 | 763,240,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 32,113,000 | shares | 92 |
| 2025-01-01 to 2025-09-30 | 32,114,000 | shares | 273 |
| 2024-07-01 to 2024-09-30 | 32,026,000 | shares | 92 |
| 2024-01-01 to 2024-09-30 | 32,030,000 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 32,149,000 | shares | 92 |
| 2025-01-01 to 2025-09-30 | 32,158,000 | shares | 273 |
| 2024-07-01 to 2024-09-30 | 32,266,000 | shares | 92 |
| 2024-01-01 to 2024-09-30 | 32,266,000 | shares | 274 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 2.05 | USD/shares | 92 |
| 2025-01-01 to 2025-09-30 | 4.37 | USD/shares | 273 |
| 2024-07-01 to 2024-09-30 | 1.94 | USD/shares | 92 |
| 2024-01-01 to 2024-09-30 | 4.37 | USD/shares | 274 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 2.05 | USD/shares | 92 |
| 2025-01-01 to 2025-09-30 | 4.36 | USD/shares | 273 |
| 2024-07-01 to 2024-09-30 | 1.93 | USD/shares | 92 |
| 2024-01-01 to 2024-09-30 | 4.34 | USD/shares | 274 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 24,282,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 55,218,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 23,571,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 54,974,000 | USD | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 186,206,000 | USD | |
| At 2024-12-31 | 153,773,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 370,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 1,313,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 600,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 1,768,000 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 108,556,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 242,809,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 105,994,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 238,796,000 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 990,738,000 | USD | |
| At 2024-12-31 | 914,832,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 302,773,000 | USD | |
| At 2024-12-31 | 332,427,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 66,985,000 | USD | |
| At 2024-12-31 | 91,049,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 363,624,000 | USD | |
| At 2024-12-31 | 274,705,000 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 388,302,000 | USD | |
| At 2024-12-31 | 371,920,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 272,817,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 709,883,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 271,160,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 694,302,000 | USD | 274 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 164,261,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 467,074,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 165,166,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 455,506,000 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 32,064,728 | shares | |
| At 2024-12-31 | 32,110,170 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 109,006,000 | USD | |
| At 2024-12-31 | 106,702,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | -4,780,000 | USD | |
| At 2024-12-31 | -72,239,000 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 1,104,495,000 | USD | |
| At 2024-12-31 | 942,645,000 | USD | |
| At 2024-09-30 | 985,129,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 24,558,000 | USD | |
| At 2024-12-31 | 24,603,000 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 328,220,000 | USD | |
| At 2024-12-31 | 282,484,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 19,666,000 | USD | |
| At 2024-12-31 | 18,535,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 152,624,000 | USD | |
| At 2024-12-31 | 172,758,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 83,279,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 179,879,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 76,835,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 176,736,000 | USD | 274 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 62,628,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 207,748,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 84,482,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 147,677,000 | USD | 274 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 18,836,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 18,201,000 | USD | 274 |
Nonoperating interest expense
Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 2,305,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 5,637,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 1,978,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 5,726,000 | USD | 274 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 978,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 1,302,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | -1,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 35,000 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | -995,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | -7,712,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | -5,588,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -7,086,000 | USD | 274 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 3,454,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | -4,909,000 | USD | 274 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 4,993,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 6,578,000 | USD | 274 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 55,948,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 48,643,000 | USD | 274 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 5,000,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 4,400,000 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 62,901,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 102,576,000 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | -18,749,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 35,237,000 | USD | 274 |
Inspect the source
- Entity
- INTERPARFUMS, INC. / CIK 0000822663
- Captured
- 2026-09-19T15:07:35.758Z
- SEC response SHA-256
b28ba276a652f6ab89fe8d9b8a41ee63aff5eb154a01990e4ea5531c9183454d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000822663.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))